Tarsus Pharmaceuticals
TARS
TARS
157 hedge funds and large institutions have $1.43B invested in Tarsus Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 58 increasing their positions, 34 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
35% more funds holding
Funds holding: 116 → 157 (+41)
1.76% more ownership
Funds ownership: 103.11% → 104.86% (+1.8%)
Holders
157
Holding in Top 10
7
Calls
$7.46M
Puts
$4.29M
Top Buyers
| 1 | +$66.8M | |
| 2 | +$48.4M | |
| 3 | +$30M | |
| 4 |
BCM
Boone Capital Management
Atlanta,
Georgia
|
+$22.1M |
| 5 |
IHAM
Integral Health Asset Management
New York
|
+$17.8M |
Top Sellers
| 1 | -$55.1M | |
| 2 | -$44.3M | |
| 3 | -$12.7M | |
| 4 |
TCM
TCG Crossover Management
Palo Alto,
California
|
-$12.7M |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$8.18M |